A

nd so, another working week will soon draw to a close. Not a moment too soon, yes? This is, as you know, our treasured signal to daydream about weekend plans. Our agenda is rather busy, as we plan to deposit one of the short people at a summer destination and, otherwise, tend to a lengthy list of sundry matters. And what about you? This is a lovely time of year to enjoy the great outdoors. You could investigate a new hobby. Take a break from the news — real or imagined. Or simply plan the rest of your life. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

Health and Human Services Secretary Tom Price is continuing to push the Senate to further increase the industry fees paid to the Food and Drug Administration, Regulatory Focus writes. The move would upend the agreed-to amounts negotiated by FDA and the pharmaceutical industry for the next five years — and allow for further cuts to the agency’s congressional appropriations.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy